Washington Trust Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.31K Hold
28
– – ﹤0.01% 565
2026
Q1
$5.36K Hold
28
– – ﹤0.01% 529
2025
Q4
$5.64K Sell
28
-2
-7% -$404 ﹤0.01% 539
2025
Q3
$6.19K Hold
30
– – ﹤0.01% 592
2025
Q2
$5.37K Hold
30
– – ﹤0.01% 563
2025
Q1
$4.1K Buy
+30
New +$3.95K ﹤0.01% 567
2024
Q4
– Sell
-10
Closed -$1.68K – 684
2024
Q3
$1.68K Buy
+10
New +$1.51K ﹤0.01% 643
2022
Q4
– Sell
-746
Closed -$38K – 889
2022
Q3
$38K Buy
746
+286
+62% +$17K ﹤0.01% 426
2022
Q2
$24K Buy
460
+62
+16% +$4.32K ﹤0.01% 514
2022
Q1
$34K Buy
+398
New +$32.7K ﹤0.01% 502

Other funds holding THC

Washington Trust Advisors's THC Position: Q2 2026 in Review

Washington Trust Advisors held its Tenet Healthcare (THC) position steady in Q2 2026 at 28 shares worth $5.31K. The position accounts for ﹤0.01% of the portfolio, ranked #565.

Washington Trust Advisors first reported a position in THC in Q1 2022 and has held it in 10 quarters since. The position peaked at $38K in Q3 2022. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Washington Trust Advisors held 28 shares of Tenet Healthcare worth $5.31K as of Q2 2026.
  • Washington Trust Advisors left its Tenet Healthcare share count unchanged in Q2 2026.
  • Tenet Healthcare made up ﹤0.01% of Washington Trust Advisors's portfolio in Q2 2026, its #565 holding.
  • Washington Trust Advisors first reported a position in Tenet Healthcare in Q1 2022 and has held it in 10 quarters since.
  • Washington Trust Advisors's Tenet Healthcare position peaked at $38K in Q3 2022.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.